$HITI There are a whole range of active non-intoxicating and non-regulated (like CBD) cannabinoids in cannabis that have been identified, through research and through anecdotal reports as producing various life enhancing and remedial effects on various symptoms and conditions. APPOINT A DERIVATIVES CZAR: Expanding the production and promotion of legal, non-thc containing cannabis derivative SKU's is something that HITI should pursue with extreme vigor. To facilitate this HITI should immediately appoint a Derivatives Czar tasked with the responsibility to create a small and agile HITI division focused solely on building out HITI's existing cannabinoid manufacturing infrastructure and to launching and promoting new cannabinoid derivative SKU's as quickly as possible. Cannabis Retail is much more then THC containing products. We can't wait for US legislation and legalization to begin aggressively marketing HITI manufactured derivative products globally, and we don't need too.
2
2
2 Likes